Literature DB >> 12742895

Liver cancer in low and middle income countries.

Andrew J Hall, Christopher P Wild.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12742895      PMCID： PMC1125959          DOI： 10.1136/bmj.326.7397.994

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Some traditional herbal medicines, some mycotoxins, naphthalene and styrene.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  2002

Review 2.  Global cancer statistics in the year 2000.

Authors:  D M Parkin
Journal:  Lancet Oncol       Date:  2001-09       Impact factor: 41.316

Review 3.  Cancer and infection: estimates of the attributable fraction in 1990.

Authors:  P Pisani; D M Parkin; N Muñoz; J Ferlay
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-06       Impact factor: 4.254

4.  Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.

Authors:  M H Chang; C J Chen; M S Lai; H M Hsu; T C Wu; M S Kong; D C Liang; W Y Shau; D S Chen
Journal:  N Engl J Med       Date:  1997-06-26       Impact factor: 91.245

5.  Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age.

Authors:  S Viviani; A Jack; A J Hall; N Maine; M Mendy; R Montesano; H C Whittle
Journal:  Vaccine       Date:  1999-08-06       Impact factor: 3.641

Review 6.  Primary prevention of hepatocellular carcinoma in developing countries.

Authors:  C P Wild; A J Hall
Journal:  Mutat Res       Date:  2000-04       Impact factor: 2.433

Review 7.  The role of aflatoxins and hepatitis viruses in the etiopathogenesis of hepatocellular carcinoma: A basis for primary prevention in Guinea-Conakry, West Africa.

Authors:  Paul C Turner; Abdoulaye Sylla; Mamadou S Diallo; Jean-Jacques Castegnaro; Andrew J Hall; Christopher P Wild
Journal:  J Gastroenterol Hepatol       Date:  2002-12       Impact factor: 4.029

Review 8.  Strategies for chemoprevention of liver cancer.

Authors:  Thomas W Kensler; Patricia A Egner; Jin-Bing Wang; Yuan-Rong Zhu; Bao-Chu Zhang; Geng-Sun Qian; Shuang-Yuan Kuang; Stephen J Gange; Lisa P Jacobson; Alvaro Muñoz; John D Groopman
Journal:  Eur J Cancer Prev       Date:  2002-08       Impact factor: 2.497

9.  A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China.

Authors:  G S Qian; R K Ross; M C Yu; J M Yuan; Y T Gao; B E Henderson; G N Wogan; J D Groopman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994 Jan-Feb       Impact factor: 4.254
  9 in total
  11 in total

1.  Epidemiologic risk factors of hepatocellular carcinoma in a rural region of Egypt.

Authors:  Amr S Soliman; Chu-Wei Hung; Alexander Tsodikov; Ibrahim A Seifeldin; Mohamed Ramadan; Dina Al-Gamal; Emily L Schiefelbein; Priyanka Thummalapally; Subhojit Dey; Kadry Ismail
Journal:  Hepatol Int       Date:  2010-08-19       Impact factor: 6.047

Review 2.  Association between the presence of H pylori in the liver and hepatocellular carcinoma: a meta-analysis.

Authors:  Shi-Ying Xuan; Yong-Ning Xin; An-Jin Chen; Quan-Jiang Dong; Xin Qiang; Ning Li; Ming-Hua Zheng; Hua-Shi Guan
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

3.  Helicobacter infection in hepatocellular carcinoma tissue.

Authors:  Shi-Ying Xuan; Ning Li; Xin Qiang; Rong-Rong Zhou; Yong-Xin Shi; Wen-Jie Jiang
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

Review 4.  Risk factors for primary liver carcinoma in Chinese population.

Authors:  Rui-Hong Luo; Zhi-Xin Zhao; Xu-Yu Zhou; Zhi-Liang Gao; Ji-Lu Yao
Journal:  World J Gastroenterol       Date:  2005-07-28       Impact factor: 5.742

5.  Hepatitis B control by 2012 in the WHO Western Pacific Region: rationale and implications.

Authors:  Manju Rani; Baoping Yang; Richard Nesbit
Journal:  Bull World Health Organ       Date:  2009-09       Impact factor: 9.408

Review 6.  Extragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases.

Authors:  Elizabeth Ma Rabelo-Gonçalves; Bruna M Roesler; José Mr Zeitune
Journal:  World J Hepatol       Date:  2015-12-28

7.  Global geographical overlap of aflatoxin and hepatitis C: controlling risk factors for liver cancer worldwide.

Authors:  D L Palliyaguru; F Wu
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2013-01-02

8.  Rosiglitazone sensitizes hepatocellular carcinoma cell lines to 5-fluorouracil antitumor activity through activation of the PPARgamma signaling pathway.

Authors:  Liang-qi Cao; Xiao-li Wang; Qian Wang; Ping Xue; Xing-yuan Jiao; He-ping Peng; Hai-wu Lu; Qiang Zheng; Xi-lin Chen; Xiao-hui Huang; Xin-hui Fu; Jing-song Chen
Journal:  Acta Pharmacol Sin       Date:  2009-08-17       Impact factor: 6.150

9.  Berbamine induces apoptosis in human hepatoma cell line SMMC7721 by loss in mitochondrial transmembrane potential and caspase activation.

Authors:  Guan-yu Wang; Jia-wei Zhang; Qing-hua Lü; Rong-zhen Xu; Qing-hua Dong
Journal:  J Zhejiang Univ Sci B       Date:  2007-04       Impact factor: 3.066

10.  Synergistic effect of puerarin and 5-fluorouracil on hepatocellular carcinoma.

Authors:  Yan-Ping Zeng; Zi-Rong Yang; Xu-Feng Guo; Wang Jun; Wei-Guo Dong
Journal:  Oncol Lett       Date:  2014-09-15       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.